David L. Hava
Keine laufenden Positionen mehr
Profil
David L.
Hava served as the Chief Scientific Officer at Pulmatrix Operating Co., Inc. and Pulmatrix, Inc. from 2015 to 2018.
He also held the position of Chief Scientific Officer at Metera Pharmaceuticals, Inc. Currently, he is the Head of Research & Development at Synlogic, Inc. Dr. Hava obtained a doctorate degree from Tufts University.
Ehemalige bekannte Positionen von David L. Hava
| Unternehmen | Position | Ende |
|---|---|---|
| SYNLOGIC, INC. | Chief Tech/Sci/R&D Officer | 01.06.2023 |
| PULMATRIX, INC. | Chief Tech/Sci/R&D Officer | 01.12.2018 |
Metera Pharmaceuticals, Inc.
 Metera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Metera Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Newton, MA. | Chief Tech/Sci/R&D Officer | - |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von David L. Hava
| Tufts University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PULMATRIX, INC. | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Health Technology |
Metera Pharmaceuticals, Inc.
Metera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Metera Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Newton, MA. | Health Technology |
